Exelixis, Inc. (NASDAQ: EXEL) reported Q2 EPS of ($0.38), $0.01 better than the analyst estimate of ($0.39). Revenue for the quarter came in at $6.6 million versus the consensus estimate of $5.66 million.

For earnings history and earnings-related data on Exelixis, Inc. (EXEL) click here.